Phase 2 Readout
ABCL: Phase 2 Readout: abcl635
September 30, 2026 · abcl635. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 30, 2026
- Company
- AbCellera Biologics Inc. (ABCL)
- Drug
- abcl635
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: abcl635
- Drug
- abcl635
- Indication
- hot flash